Tuberculosis (4th Ed.)
The Essentials, Fourth Edition

Lung Biology in Health and Disease Series

Coordinator: Raviglione Mario C.

Language: English

244.87 €

Subject to availability at the publisher.

Add to cartAdd to cart
Tuberculosis
Publication date:
Support: Print on demand

121.86 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Tuberculosis
Publication date:
· 15.2x22.9 cm · Paperback

Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis: The Essentials scrutinizes the new discoveries and observations of the key aspects of the disease. Recognized world experts provide a concise, state-of-the-art review of the 15 essential elements of TBsupply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methodsdiscuss the emerging threat of XDR-TB and the HIV/AIDS factorassess advances in TB research such as new drugs and vaccinesreflect on the progress of the "Stop TB" strategy.

See What?s New in the Fourth Edition:

  • Updated chapters on epidemiology and pathogenesis provide new insights on TB infection and disease
  • Updated chapters on diagnosis and treatment cover new tests and molecular detection methods
  • Information on developing effective regiments and discussion of situations deserving specific precautions
  • Coverage of adherence issues

The book book is an essential guide for everybody working in the field of TB, from specialists to nurses and students, both from a clinical and public health perspective.

The Global Tuberculosis Epidemic: Scale, Dynamics, and Prospects for Control. The Epidemiology of Tuberculosis
Pathogenesis of Tuberculosis: New Insights. Diagnosis of Pulmonary and Extrapulmonary Tuberculosis. Treatment of Tuberculosis. Tuberculosis/HIV Coinfection: Epidemiology, Clinical Aspects, and Programmatic Interventions. Achieving Higher Case Detection and Cure Rates: National Programs and Beyond. Antituberculosis Drug Resistance in the World: The Latest Information. Programmatic Control of Multidrug-Resistant Tuberculosis
Programmatic Management of HIV-Associated Tuberculosis. WHO's Stop TB Strategy: Progress and Prospects
New Drugs for Tuberculosis. The Future of Tuberculosis Vaccinology.

Professional and Professional Reference
Mario C. Raviglione